Counterpoint: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Oncology (Williston Park, N.Y.)
Volume	32
State	Published - Sep 15 2018

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Other files and links

Link to repository

Cite this

@article{301d1136fa254adfbc385f43f425626b,

title = "Counterpoint: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?",

author = "Diaz, {John Paul}",

note = "Oncology (Williston Park, N.Y.) (2018) 32(9):455, 458-9, 462",

year = "2018",

month = sep,

day = "15",

language = "American English",

volume = "32",

journal = "Oncology (Williston Park, N.Y.)",

}

TY - JOUR

T1 - Counterpoint: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?

AU - Diaz, John Paul

N1 - Oncology (Williston Park, N.Y.) (2018) 32(9):455, 458-9, 462

PY - 2018/9/15

Y1 - 2018/9/15

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/2922

M3 - Article

VL - 32

JO - Oncology (Williston Park, N.Y.)

JF - Oncology (Williston Park, N.Y.)

ER -